Professor

Sang-Hyun Min
Chair, Department of Innovative Pharmaceutical Sciences

Field of Expertise: Cancer Molecular Biology / Pharmacology

Research Interests:

Phone: 053-950-4542
Email: shmin03@knu.ac.kr

Educatoin and Training

Ph.D. 2007 – 2009
KAIST, Department of Biological Sciences / Interdisciplinary Program in Medical Science

B.S. – M.S. 1990 – 1999
Chungbuk National University, Department of Biology

Professional Experiences

2024 – Present
Professor / Head, Department of Innovative Drug Development, Kyungpook National University

2012 – 2024
Principal Researcher, New Drug Development Support Center, K-MEDI Hub

2013 – 2024
Adjunct Professor, School of Biological Sciences, Kyungpook National University

2009 – 2012
Research Fellow, Harvard Medical School (Beth Israel Deaconess Medical Center, BIDMC)

2006 – 2009
Researcher / Post-doctoral Fellow, KAIST

1999 – 2006
Researcher, Korea Research Institute of Bioscience and Biotechnology (KRIBB)

2023 – 2025 Expert Committee Member (9th Term), Korea Technology Commercialization Agency (Ministry of Science and ICT)
2022 Member, Core Technology Committee for Infectious Disease Research, Ministry of Science and ICT
Technical Committee Member, KoNSCRT (Korean Network for Stem Cell Research and Therapy), Ministry of Science and ICT
Subcommittee Member, Preliminary Feasibility Study Committee on Stem Cell Research, Ministry of Science and ICT
Working Group Member, Bio-Health R&D Investment Strategy Task Force, Ministry of Science and ICT
Expert Member, Daegu Future Industry Promotion Division (Medical Industry)
Advisor, Daegu Investment Promotion Office
Project Manager (Top 10 Industries), Daegu Regional Industrial Economic Planning and Analysis Program
Working Group Member, Daegu Technopark Industrial Economic Development Roadmap Project
Member, Institutional Review Board (IRB), Chilgok Kyungpook National University Hospital
Chair, Publication Committee / Representative, Industry-Academic Cooperation Committee, Korean Society for Biochemistry and Molecular Biology
Chair, Industry-Academic Cooperation Committee, Korean Society for Stem Cell Research
Regular Member, Korean Pharmaceutical Society
Regular Member, Korean Society for Molecular and Cellular Biology

Screening platform technology for Alzheimer's disease therapeutics – December 2024
Therapeutic agent for ovarian cancer stem cells – April 2022
Pharmaceutical composition for the prevention or treatment of cancer and inflammatory diseases – February 2022
Therapeutic agent for cancer and cancer stem cells – February 2018
Targeted therapeutic agent for liver cancer – January 2018

Minister of Health and Welfare Award – Excellence in Health Industry Promotion (Outstanding Researcher Award), 2019
National Graduate Science & Technology Scholarship, National Research Foundation of Korea (NRF), 2007

Sang-Hyun Min and Byeong-Mo Kim. Pharmacological Inhibition of Pin1 for Cancer Therapy.
SM Group Open Access eBooks – Cancer Therapy, May 20, 2016.
Dong-Kyu Choi, Yong-Kyu Kim, Ji Hoon Yu, Sang-Hyun Min, and Sang-Wook Park.
Genome Editing of hPSCs: Recent Progress in hPSC-Based Disease Modeling for Understanding Disease Mechanisms.
Progress in Molecular Biology and Translational Science, April 15, 2021.

Page updated

Google Sites

Report abuse